Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2012, Article ID 646195, 5 pages
http://dx.doi.org/10.1155/2012/646195
Case Report

Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation

1Section of Adult Hematology and Hematopoietic, Stem Cell Transplant, Oncology Center, King Fahad Specialist Hospital, P.O. Box 15215, Dammam 31444, Saudi Arabia
2Section of Microbiology, Department of Pathology and Laboratory Medicine, King Fahad Specialist Hospital, P.O. Box 15215, Dammam 31444, Saudi Arabia

Received 22 April 2012; Accepted 5 July 2012

Academic Editors: M. G. . H. Betjes, C. Costa, and M. Klinger

Copyright © 2012 Khalid Ahmed Al-Anazi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Busca, F. Locatelli, A. Barbui et al., “Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation,” Transplant Infectious Disease, vol. 5, no. 3, pp. 132–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Safdar, G. H. Rodriguez, C. N. Mihu et al., “Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention,” Bone Marrow Transplantation, vol. 45, no. 2, pp. 339–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. P. Baughman, “The use of carbapenems in the treatment of serious infections,” Journal of Intensive Care Medicine, vol. 24, no. 4, pp. 230–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Butt, R. K. Afzal, R. N. Ahmad, M. Salman, A. Mahmood, and M. Anwar, “Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern,” Journal of Ayub Medical College, Abbottabad, vol. 16, no. 1, pp. 18–22, 2004. View at Google Scholar · View at Scopus
  5. I. Ghosh, V. Raina, L. Kumar et al., “Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India,” Medical Oncology, vol. 29, no. 2, pp. 1354–1360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Cisneros, M. J. Reyes, J. Pachón et al., “Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features,” Clinical Infectious Diseases, vol. 22, no. 6, pp. 1026–1032, 1996. View at Google Scholar · View at Scopus
  7. J. Pachón and J. Vila, “Treatment of multiresistant Acinetobacter baumannii infections,” Current Opinion in Investigational Drugs, vol. 10, no. 2, pp. 150–156, 2009. View at Google Scholar · View at Scopus
  8. D. E. Karageorgopoulos, T. Kelesidis, I. Kelesidis, and M. E. Falagas, “Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 1, pp. 45–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Cisneros and J. Rodriguez-Baño, “Nosocomial bactermia due to Acinetobacter baumannii: epidemiology, clinical features and treatment,” Clinical Microbiology and Infection, vol. 8, no. 11, pp. 687–693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Seifert, A. Strate, and G. Pulverer, “Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality,” Medicine, vol. 74, no. 6, pp. 340–349, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. G. Tilley and F. J. Roberts, “Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings,” Clinical Infectious Diseases, vol. 18, no. 6, pp. 896–900, 1994. View at Google Scholar · View at Scopus
  12. L. L. Maragakis and T. M. Perl, “Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1254–1263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Y. Peleg, H. Seifert, and D. L. Paterson, “Acinetobacter baumannii: emergence of a successful pathogen,” Clinical Microbiology Reviews, vol. 21, no. 3, pp. 538–582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Poutanen, M. Louie, and A. E. Simor, “Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 16, no. 10, pp. 737–740, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. C. K. Murray and D. R. Hospenthal, “Treatment of multidrug resistant Acinetobacter,” Current Opinion in Infectious Diseases, vol. 18, no. 6, pp. 502–506, 2005. View at Google Scholar · View at Scopus
  16. S. J. Chen, T. F. Chao, M. C. Chiang et al., “Prediction of patient outcome from Acinetobacter baumannii bacteremia with sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation (APACHE) II scores,” Internal Medicine, vol. 50, no. 8, pp. 871–877, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. García-Garmendia, C. Ortiz-Leyba, J. Garnacho-Montero et al., “Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study,” Clinical Infectious Diseases, vol. 33, no. 7, pp. 939–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. T. Wang, L. C. McDonald, S. C. Chang, and M. Ho, “Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan,” Journal of Clinical Microbiology, vol. 40, no. 4, pp. 1526–1529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Vila and J. Pachón, “Therapeutic options for Acinetobacter baumannii infections,” Expert Opinion on Pharmacotherapy, vol. 9, no. 4, pp. 587–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Beck-Sague, W. R. Jarvis, J. H. Brook et al., “Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units,” American Journal of Epidemiology, vol. 132, no. 4, pp. 723–733, 1990. View at Google Scholar · View at Scopus
  21. A. Michalopoulos and M. E. Falagas, “Treatment of Acinetobacter infections,” Expert Opinion on Pharmacotherapy, vol. 11, no. 5, pp. 779–788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Rossolini and E. Mantengoli, “Antimicrobial resistance in Europe and its potential impact on empirical therapy,” Clinical Microbiology and Infection, vol. 14, no. 6, pp. 2–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. Falagas and P. Kopterides, “Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature,” Journal of Hospital Infection, vol. 64, no. 1, pp. 7–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. J. Ye, C. T. Huang, S. S. Shie et al., “Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains,” PLoS ONE, vol. 5, no. 4, Article ID e9947, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. O. Lee, N. J. Kim, S. H. Choi et al., “Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 224–228, 2004. View at Google Scholar
  26. S. K. Lim, S. O. Lee, S. H. Choi et al., “The outcomes of using colistin for treating multidrug resistant Acinetobacter species bloodstream infections,” Journal of Korean Medical Science, vol. 26, no. 3, pp. 325–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Blot, K. Vandewoude, and F. Colardyn, “Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study,” Intensive Care Medicine, vol. 29, no. 3, pp. 471–475, 2003. View at Google Scholar · View at Scopus